Evidence map›Paper›PMID 31134444›Full record

ArticleWorld journal of microbiology & biotechnology2019

High-level secretive expression of a novel achieved Talaromyces cellulolyticus endo-polygalacturonase in Pichia pastoris by improving gene dosage for hydrolysis of natural pectin.

Xiao-Bo Peng, Guang-Jun Chen, Zhen-Gang Han, Jiang-Ke Yang

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiao-Bo PengCollege of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, 430023, China.
Guang-Jun ChenCollege of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, 430023, China.
Zhen-Gang HanCollege of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, 430023, China.
Jiang-Ke YangCollege of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, 430023, China. jiangke.yang@gmail.com.ORCID http://orcid.org/0000-0001-6234-451X
Wuhan Polytechnic University · CN

Funding

China Ocean Mineral Resources R & D Association DY135-B2-06
6 · The paper itself

Abstract

Pectin is a type of complex hydrophilic polysaccharide widely distributed in plant resources. Thermal stable pectinase has its advantage in bioapplication in the fields of food processing, brewing, and papermaking, etc. In this study, we enzymatically characterized a putative endo-polygalacturonase TcPG from a Talaromyces cellulolyticus, realized its high-level expression in Pichia pastoris by in vitro constructing of a series of multi-copy expression cassettes and real time quantitative PCR screening. The secretive expression level of TcPG was nonlinear correlated to the gene dosage. Recombinants with five-copy TcPG gene in the host genome showed the highest expression. After cultivation in a bioreactor for about 96 h, the enzyme activity reached 7124.8 U/mL culture. TcPG has its optimal temperature of 70 °C. Under the optimized parameters, the pectin could be efficiently hydrolyzed into oligosaccharides.

Indexed as

Gene DosageBioreactorsCloning, MolecularGene Expression Regulation, FungalHydrolysisPectinsPichiaPolygalacturonaseReal-Time Polymerase Chain ReactionRecombinant ProteinsTalaromycesTemperatureTime FactorsPectinsPolygalacturonaseRecombinant ProteinsGene dosageParameters optimizationPectinaseReal time quantitative PCRThermal stable

Identifiers

PMID31134444
OpenAlexW2947463776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.